Skip to content

Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography

Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07443579
Acronym
MammoView
Enrollment
400
Registered
2026-03-02
Start date
2026-02-24
Completion date
2030-12-31
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Breast Cancer Recurrence, Post Treatment Surveillance

Keywords

Surveillance Mammography, Mammography View Sequencing, Mammography Technique, Breast Imaging

Brief summary

This prospective, single-centre, parallel-group randomised controlled trial evaluates the optimal sequencing of mammography views in women with a history of breast cancer undergoing surveillance mammography. Women treated with breast-conserving surgery within the previous five years will be randomised 1:1:1:1 to one of four mammography view sequencing groups. The primary objective is to compare patient-reported pain and satisfaction across sequencing groups. Secondary objectives include comparison of image quality (PGMI scoring), compression force, and breast thickness. A total of 400 participants will be enrolled at Beaumont Hospital Breast Care Centre over 2.5 years.

Detailed description

Women with a history of breast cancer routinely undergo annual surveillance mammography following breast-conserving surgery and radiotherapy. Standard mammography includes mediolateral oblique (MLO) and craniocaudal (CC) views of each breast. However, there is limited evidence regarding whether the order in which these views are obtained affects patient experience or image quality. This study randomises 400 women (1:1:1:1) to four different view sequencing protocols: 1. Untreated MLO --- Treated MLO --- Untreated CC --- Treated CC 2. Untreated CC --- Treated CC --- Untreated MLO --- Treated MLO 3. Treated MLO --- Untreated MLO --- Treated CC --- Untreated CC 4. Treated CC --- Untreated CC --- Treated MLO --- Untreated MLO Pain is assessed using a visual analogue scale (VAS) before and after mammography. Patient satisfaction is measured using a post-procedure questionnaire. Image quality will be assessed retrospectively using PGMI scoring by two radiologists. Compression force and breast thickness will also be recorded. The study uses an intention-to-treat analysis framework.

Interventions

PROCEDUREMammography View Sequencing

Standard surveillance mammography consisting of MLO and CC views of both treated and untreated breasts. Participants are randomised to one of four predefined sequences determining the order in which views are obtained. No additional imaging beyond standard of care is performed.

Sponsors

Royal College of Surgeons, Ireland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Participants will be randomised in a 1:1:1:1 ratio to one of four mammography view sequencing groups. Each group undergoes standard surveillance mammography consisting of mediolateral oblique (MLO) and craniocaudal (CC) views of both treated and untreated breasts, performed in a different predefined sequence. The intervention involves the order in which views are obtained. All participants receive the same imaging views; only the sequence differs. There is no crossover between groups. Analysis will be conducted on an intention-to-treat basis.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Female patients aged 18 years or older History of breast cancer treated with breast-conserving surgery (wide local excision) Undergoing first annual surveillance mammogram following completion of surgery and radiotherapy Within five years of breast cancer treatment May have history of whole-breast or partial-breast radiotherapy May have history of axillary surgery Able and willing to provide informed consent

Exclusion criteria

Male patients Patients younger than 18 years History of mastectomy History of bilateral wide local excision Lack of capacity to provide informed consent More than five years since completion of breast cancer treatment

Design outcomes

Primary

MeasureTime frameDescription
Change in Patient-Reported Pain Score During MammographyImmediately before and immediately after mammography (same study visit)Pain will be measured using a 10-point Visual Analogue Scale (VAS). Pain scores will be recorded immediately prior to mammography and immediately following completion of mammography. The primary analysis will compare post-procedure pain scores across the four randomised sequencing groups.
Patient Satisfaction Following MammographyImmediately after mammography (same study visit)Patient satisfaction will be assessed immediately after mammography using a structured electronic questionnaire administered via MS Forms. Responses will be compared across the four sequencing groups.

Secondary

MeasureTime frameDescription
Image Quality (PGMI Score)Following image acquisition (retrospective review after mammography during normal reporting timeframe institutionally)Image quality will be assessed retrospectively using the PGMI (Perfect, Good, Moderate, Inadequate) scoring system by two radiologists. PGMI scores will be compared across sequencing groups.
Compression Force During MammographyDuring mammography (same study visit)Compression force applied during mammography will be recorded in Newtons from the mammography unit and compared across sequencing groups.
Breast Thickness During MammographyDuring mammography (same study visit)Compressed breast thickness will be recorded in millimetres from the mammography system and compared across sequencing groups.
Mean Glandular Radiation DoseDuring mammography (same study visit)Mean glandular dose (MGD) will be recorded from the mammography unit for each participant and compared across sequencing groups.
Duration of Mammography ProcedureDuring mammography (same study visit)Total time taken to complete mammography will be recorded in minutes and compared across sequencing groups.

Countries

Ireland

Contacts

CONTACTProf Nuala Healy
nualahealy@rcsi.ie+35318093000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026